SGLT2 inhibition mitigates perturbations in nephron segment-specific metabolic transcripts and mTOR pathway activity in kidneys of young persons with type 2 diabetes

Jennifer A. Schaub, Fadhl M. AlAkwaa, Phillip J. McCown, Abhijit S. Naik, Viji Nair, Sean Eddy, Rajasree Menon, Edgar A. Otto, John Hartman, Damian Fermin, Christopher O’Connor, Markus Bitzer, Roger Harned, Patricia Ladd, Laura Pyle, Jeffrey B. Hodgin, Frank C. Brosius III, Robert G. Nelson, Matthias Kretzler, Petter Bjornstad
doi: https://doi.org/10.1101/2022.07.23.22277943

Data Availability

Data produced in the present study are available upon reasonable request to the authors and based on approval from respective study governing committees. Data produced as part of the present work are contained in the supplemental files.

Back to top
Posted July 24, 2022.
Download PDF

Supplementary Material

Data/Code
Email
SGLT2 inhibition mitigates perturbations in nephron segment-specific metabolic transcripts and mTOR pathway activity in kidneys of young persons with type 2 diabetes
Jennifer A. Schaub, Fadhl M. AlAkwaa, Phillip J. McCown, Abhijit S. Naik, Viji Nair, Sean Eddy, Rajasree Menon, Edgar A. Otto, John Hartman, Damian Fermin, Christopher O’Connor, Markus Bitzer, Roger Harned, Patricia Ladd, Laura Pyle, Jeffrey B. Hodgin, Frank C. Brosius III, Robert G. Nelson, Matthias Kretzler, Petter Bjornstad
medRxiv 2022.07.23.22277943; doi: https://doi.org/10.1101/2022.07.23.22277943
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area